AR028338A1 - Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis - Google Patents
Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesisInfo
- Publication number
- AR028338A1 AR028338A1 ARP010101775A ARP010101775A AR028338A1 AR 028338 A1 AR028338 A1 AR 028338A1 AR P010101775 A ARP010101775 A AR P010101775A AR P010101775 A ARP010101775 A AR P010101775A AR 028338 A1 AR028338 A1 AR 028338A1
- Authority
- AR
- Argentina
- Prior art keywords
- synthesis
- compositions
- materials
- pharmaceutical uses
- antipicornaviral compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19779600P | 2000-04-14 | 2000-04-14 | |
| US19849700P | 2000-04-18 | 2000-04-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR028338A1 true AR028338A1 (es) | 2003-05-07 |
Family
ID=26893177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010101775A AR028338A1 (es) | 2000-04-14 | 2001-04-17 | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US6610730B2 (es) |
| EP (1) | EP1274682A2 (es) |
| JP (1) | JP2003531139A (es) |
| KR (1) | KR20030019350A (es) |
| CN (1) | CN1431995A (es) |
| AR (1) | AR028338A1 (es) |
| AU (1) | AU2001251639A1 (es) |
| BR (1) | BR0110077A (es) |
| CA (1) | CA2406475A1 (es) |
| HU (1) | HUP0300928A3 (es) |
| IL (1) | IL152243A0 (es) |
| MX (1) | MXPA02010195A (es) |
| PA (1) | PA8515201A1 (es) |
| PE (1) | PE20011277A1 (es) |
| PL (1) | PL365198A1 (es) |
| SV (1) | SV2001000379A (es) |
| UY (1) | UY26666A1 (es) |
| WO (1) | WO2001079167A2 (es) |
| ZA (1) | ZA200208257B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL163868A0 (en) | 2002-03-22 | 2005-12-18 | Eisai Co Ltd | Hermiasterlin derivatives and uses thereof |
| US7064211B2 (en) | 2002-03-22 | 2006-06-20 | Eisai Co., Ltd. | Hemiasterlin derivatives and uses thereof |
| WO2005066123A1 (en) * | 2003-12-31 | 2005-07-21 | Taigen Biotechnology | Protease inhibitors |
| US7462594B2 (en) * | 2003-12-31 | 2008-12-09 | Taigen Biotechnology Co., Ltd. | Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
| KR100891699B1 (ko) | 2007-04-10 | 2009-04-03 | 광주과학기술원 | 7-아미노-4-((ｓ)-3-(4-플루오로페닐)-2-((r)-3-메틸-2-(5-메틸이소옥사졸-3-카복사미도)부탄아미도)프로판아미도)-7-옥소-2-헵테노에이트 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 및 치료용 약학적 조성물 |
| EP2252144B1 (fr) | 2008-01-25 | 2023-08-02 | Rhodia Operations | Utilisation d'esteramides, nouveaux esteramides et procédé de préparation d'esteramides |
| US8450500B2 (en) | 2008-06-04 | 2013-05-28 | Synta Pharmaceuticals Corp. | Pyrrole compounds that modulate HSP90 activity |
| CN111566108B (zh) | 2017-12-25 | 2023-03-28 | 住友化学株式会社 | 杂环化合物和含有该杂环化合物的有害节肢动物防除剂 |
| IL298324A (en) | 2020-06-10 | 2023-01-01 | Aligos Therapeutics Inc | Antiviral compounds for the treatment of coronavirus, picornavirus and novovirus infections |
| CN116648240A (zh) * | 2021-01-22 | 2023-08-25 | 中国人民解放军军事科学院军事医学研究院 | 一种环肽类病毒蛋白酶抑制剂，其制备方法，及其在抗病毒药物中的应用 |
| WO2023283256A1 (en) | 2021-07-09 | 2023-01-12 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| US12065428B2 (en) | 2021-09-17 | 2024-08-20 | Aligos Therapeutics, Inc. | Anti-viral compounds |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5374623A (en) | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
| US5486623A (en) | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
| IL112759A0 (en) | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
| IT1269511B (it) | 1994-05-17 | 1997-04-01 | Univ Degli Studi Milano | Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione |
| US5523312A (en) * | 1994-09-27 | 1996-06-04 | Sterling Winthrop Inc. | Antipicornaviral agents |
| US5498616A (en) | 1994-11-04 | 1996-03-12 | Cephalon, Inc. | Cysteine protease and serine protease inhibitors |
| CA2215211A1 (en) * | 1995-03-31 | 1996-10-03 | Takeda Chemical Industries, Ltd. | Cysteine protease inhibitor |
| US5856530A (en) | 1996-05-14 | 1999-01-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| WO1997043305A1 (en) * | 1996-05-14 | 1997-11-20 | Agouron Pharmaceuticals, Inc. | Inhibitors of picornavirus 3c proteases and methods for their use and preparation |
| WO1997049668A1 (en) | 1996-06-13 | 1997-12-31 | Smithkline Beecham Corporation | Inhibitiors of cysteine protease |
| GB9615692D0 (en) * | 1996-07-25 | 1996-09-04 | Pharmacia Spa | Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| AU736550B2 (en) | 1997-03-28 | 2001-08-02 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, compositions containing them, and methods for their use |
| US6020371A (en) | 1997-03-28 | 2000-02-01 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds compositions containing them and methods for their use |
| US6331554B1 (en) | 1997-03-28 | 2001-12-18 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, compositions containing them, and methods for their use |
| US5962487A (en) | 1997-12-16 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| TR200003159T2 (tr) * | 1998-04-30 | 2001-09-21 | Agouron Pharmaceuticals,Inc. | Antipicornaviral bileşikler, hazırlanışları ve kullanımları |
| US6369226B1 (en) | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
| BR0012970A (pt) | 1999-08-04 | 2002-04-30 | Agouron Pharma | Compostos e composições antipicornavirais, seus usos farmacêuticos e materiais para a sua sìntese |
| HUP0203315A3 (en) | 1999-08-24 | 2003-12-29 | Agouron Pharmaceuticals Inc La | Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| PE20010517A1 (es) | 1999-08-24 | 2001-05-16 | Agouron Pharma | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves |
| PA8507801A1 (es) | 1999-12-03 | 2002-08-26 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
| JP2004503533A (ja) * | 2000-06-14 | 2004-02-05 | アグロン・ファーマシュウティカルズ・インコーポレーテッド | 抗ピコルナウイルス化合物及び組成物、その医薬的使用、並びにその合成のための物質 |
-
2001
- 2001-04-11 PE PE2001000336A patent/PE20011277A1/es not_active Application Discontinuation
- 2001-04-11 PA PA20018515201A patent/PA8515201A1/es unknown
- 2001-04-12 IL IL15224301A patent/IL152243A0/xx unknown
- 2001-04-12 JP JP2001576769A patent/JP2003531139A/ja active Pending
- 2001-04-12 BR BR0110077-7A patent/BR0110077A/pt not_active IP Right Cessation
- 2001-04-12 KR KR1020027013804A patent/KR20030019350A/ko not_active Application Discontinuation
- 2001-04-12 CA CA002406475A patent/CA2406475A1/en not_active Abandoned
- 2001-04-12 EP EP01925037A patent/EP1274682A2/en not_active Withdrawn
- 2001-04-12 CN CN01810359A patent/CN1431995A/zh active Pending
- 2001-04-12 HU HU0300928A patent/HUP0300928A3/hu unknown
- 2001-04-12 MX MXPA02010195A patent/MXPA02010195A/es unknown
- 2001-04-12 PL PL01365198A patent/PL365198A1/xx not_active Application Discontinuation
- 2001-04-12 US US09/834,783 patent/US6610730B2/en not_active Expired - Fee Related
- 2001-04-12 WO PCT/US2001/012333 patent/WO2001079167A2/en not_active Application Discontinuation
- 2001-04-12 AU AU2001251639A patent/AU2001251639A1/en not_active Abandoned
- 2001-04-16 UY UY26666A patent/UY26666A1/es unknown
- 2001-04-17 SV SV2001000379A patent/SV2001000379A/es not_active Application Discontinuation
- 2001-04-17 AR ARP010101775A patent/AR028338A1/es not_active Application Discontinuation
-
2002
- 2002-10-14 ZA ZA200208257A patent/ZA200208257B/en unknown
-
2003
- 2003-05-12 US US10/435,082 patent/US6872745B2/en not_active Expired - Fee Related
-
2004
- 2004-11-12 US US10/986,109 patent/US20050101651A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02010195A (es) | 2003-04-25 |
| WO2001079167A2 (en) | 2001-10-25 |
| PA8515201A1 (es) | 2002-10-24 |
| PL365198A1 (en) | 2004-12-27 |
| HUP0300928A3 (en) | 2005-08-29 |
| UY26666A1 (es) | 2001-11-30 |
| IL152243A0 (en) | 2003-05-29 |
| KR20030019350A (ko) | 2003-03-06 |
| ZA200208257B (en) | 2003-07-25 |
| PE20011277A1 (es) | 2002-01-07 |
| US20030225042A1 (en) | 2003-12-04 |
| EP1274682A2 (en) | 2003-01-15 |
| JP2003531139A (ja) | 2003-10-21 |
| SV2001000379A (es) | 2001-10-16 |
| US20050101651A1 (en) | 2005-05-12 |
| US6610730B2 (en) | 2003-08-26 |
| WO2001079167A3 (en) | 2002-02-28 |
| BR0110077A (pt) | 2003-06-17 |
| HUP0300928A2 (hu) | 2003-08-28 |
| US20020006943A1 (en) | 2002-01-17 |
| CA2406475A1 (en) | 2001-10-25 |
| US6872745B2 (en) | 2005-03-29 |
| CN1431995A (zh) | 2003-07-23 |
| AU2001251639A1 (en) | 2001-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1524266T3 (da) | Farmaceutisk sammensætning | |
| AR028204A1 (es) | Composiciones farmaceuticas electrohiladas | |
| FI20105657A (fi) | Farmaseuttisia koostumuksia | |
| NO20024175L (no) | Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene | |
| AR027998A1 (es) | Derivados de etilendiamina y los medicamentos y composiciones farmaceuticas que los contienen | |
| ITMI20010748A0 (it) | Composizioni farmaceutiche | |
| IS6709A (is) | Fljótandi samsetningar metformíns | |
| AR028317A1 (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion | |
| NO992339D0 (no) | Farmas°ytiske formuleringer | |
| FI20011478A (fi) | Farmaseuttinen koostumus | |
| EE05020B1 (et) | Glburiidi ravimkoostis | |
| AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
| AR028074A1 (es) | Proceso para la preparacion de dihidroxiesteres y derivados de los mismos | |
| AR028338A1 (es) | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis | |
| NO20026123L (no) | Farmasöytiske sammensetninger | |
| NO20022589D0 (no) | Antipicornavirus-forbindelser og blandinger, deres farmasöytiske anvendelse og materialer for syntese av dem | |
| FI20022128A0 (fi) | Farmaseuttinen koostumus | |
| NO20031095D0 (no) | Farmasöytiske sammensetninger | |
| ATE448780T1 (de) | Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung | |
| AR028122A1 (es) | Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones | |
| IT1318401B1 (it) | Derivati di n-desacetiltiocolchicina e composizioni farmaceutiche cheli contengono. | |
| ITMI20001122A0 (it) | Procedimento di sintesi di derivati antraciclinici | |
| PT1385512E (pt) | Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos | |
| AR028324A1 (es) | Nuevos compuestos de heterocicloalquilbenzociclobutano y heteroarilbenzociclobutano, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| NO20033073D0 (no) | Farmasöytisk sammensetning inneholdende citalopram |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |